132 related articles for article (PubMed ID: 38670236)
1. ALK-rearranged renal cell carcinoma with nuclear mitotic apparatus protein 1 (NUMA1) as a fusion partner.
Gupta S; Krishna M; Cheville JC
Hum Pathol; 2024 Apr; ():. PubMed ID: 38670236
[No Abstract] [Full Text] [Related]
2. NTRK-rearranged spindle cell sarcoma of the uterine cervix with a novel NUMA1::NTRK1 fusion.
Szalai L; Vereczkey I; Szemes M; Rókusz A; Csernák E; Tóth E; Melegh Z
Virchows Arch; 2024 Mar; 484(3):527-531. PubMed ID: 38151535
[TBL] [Abstract][Full Text] [Related]
3. Novel t(5;11)(q32;q13.4) with NUMA1-PDGFRB fusion in a myeloid neoplasm with eosinophilia with response to imatinib mesylate.
Zou YS; Hoppman NL; Singh ZN; Sawhney S; Kotiah SD; Baer MR
Cancer Genet; 2017 Apr; 212-213():38-44. PubMed ID: 28449810
[TBL] [Abstract][Full Text] [Related]
4. Genetic analysis and clinicopathological features of ALK-rearranged renal cell carcinoma in a large series of resected Chinese renal cell carcinoma patients and literature review.
Yu W; Wang Y; Jiang Y; Zhang W; Li Y
Histopathology; 2017 Jul; 71(1):53-62. PubMed ID: 28199742
[TBL] [Abstract][Full Text] [Related]
5. ALK-rearranged renal cell carcinoma with TPM3::ALK gene fusion and review of the literature.
Galea LA; Hildebrand MS; Witkowski T; Joy C; McEvoy CR; Hanegbi U; Aga A
Virchows Arch; 2023 Mar; 482(3):625-633. PubMed ID: 36370168
[TBL] [Abstract][Full Text] [Related]
6. Exploration of clinicopathological features of rearranged renal cell carcinoma and TFE3, TFEB, and ALK staining performance in renal entities.
Liu Y; Li X; Fan Y; Xu H; Gu Y; Dong L; Zhou L; Yang X; Wang C
Heliyon; 2023 Apr; 9(4):e15159. PubMed ID: 37089387
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Myofibroblastic Tumor Driven by Novel
Rao N; Iwenofu H; Tang B; Woyach J; Liebner DA
J Natl Compr Canc Netw; 2018 Feb; 16(2):115-121. PubMed ID: 29439172
[TBL] [Abstract][Full Text] [Related]
8. Donor centrosome regulation of initial spindle formation in mouse somatic cell nuclear transfer: roles of gamma-tubulin and nuclear mitotic apparatus protein 1.
Van Thuan N; Wakayama S; Kishigami S; Wakayama T
Biol Reprod; 2006 May; 74(5):777-87. PubMed ID: 16407502
[TBL] [Abstract][Full Text] [Related]
9. ALK-rearranged renal cell carcinoma with a novel PLEKHA7-ALK translocation and metanephric adenoma-like morphology.
Hang JF; Chung HJ; Pan CC
Virchows Arch; 2020 Jun; 476(6):921-929. PubMed ID: 31993771
[TBL] [Abstract][Full Text] [Related]
10.
Wangsiricharoen S; Zhong M; Ranganathan S; Matoso A; Argani P
Int J Surg Pathol; 2021 Oct; 29(7):808-814. PubMed ID: 33729862
[TBL] [Abstract][Full Text] [Related]
11. ALK rearranged renal cell carcinoma (ALK-RCC): a multi-institutional study of twelve cases with identification of novel partner genes CLIP1, KIF5B and KIAA1217.
Kuroda N; Trpkov K; Gao Y; Tretiakova M; Liu YJ; Ulamec M; Takeuchi K; Agaimy A; Przybycin C; Magi-Galluzzi C; Fushimi S; Kojima F; Sibony M; Hang JF; Pan CC; Yilmaz A; Siadat F; Sugawara E; Just PA; Ptakova N; Hes O
Mod Pathol; 2020 Dec; 33(12):2564-2579. PubMed ID: 32467651
[TBL] [Abstract][Full Text] [Related]
12. HIP1-ALK, a novel ALK fusion variant that responds to crizotinib.
Fang DD; Zhang B; Gu Q; Lira M; Xu Q; Sun H; Qian M; Sheng W; Ozeck M; Wang Z; Zhang C; Chen X; Chen KX; Li J; Chen SH; Christensen J; Mao M; Chan CC
J Thorac Oncol; 2014 Mar; 9(3):285-94. PubMed ID: 24496003
[TBL] [Abstract][Full Text] [Related]
13. ALK-rearranged renal cell carcinoma (ALK-RCC): Evaluation of histomorphological and immunohistochemical features by analysis of 276 renal cell carcinoma cases in Turkey.
Doğan K; Onder E
Pathol Res Pract; 2024 Jan; 253():154951. PubMed ID: 38039739
[TBL] [Abstract][Full Text] [Related]
14. Global Interactomics Connect Nuclear Mitotic Apparatus Protein NUMA1 to Influenza Virus Maturation.
Rahim MN; Klewes L; Zahedi-Amiri A; Mai S; Coombs KM
Viruses; 2018 Dec; 10(12):. PubMed ID: 30572664
[TBL] [Abstract][Full Text] [Related]
15. Developmental defects in Huntington's disease show that axonal growth and microtubule reorganization require NUMA1.
Capizzi M; Carpentier R; Denarier E; Adrait A; Kassem R; Mapelli M; Couté Y; Humbert S
Neuron; 2022 Jan; 110(1):36-50.e5. PubMed ID: 34793694
[TBL] [Abstract][Full Text] [Related]
16. Salivary Secretory Carcinoma Harboring a Novel ALK Fusion: Expanding the Molecular Characterization of Carcinomas Beyond the ETV6 Gene.
Sasaki E; Masago K; Fujita S; Suzuki H; Hanai N; Hosoda W
Am J Surg Pathol; 2020 Jul; 44(7):962-969. PubMed ID: 32205481
[TBL] [Abstract][Full Text] [Related]
17. Role of NuMA1 in breast cancer stem cells with implications for combination therapy of PIM1 and autophagy inhibition in triple negative breast cancer.
Manupati K; Hao M; Haas M; Yeo SK; Guan JL
Res Sq; 2024 Apr; ():. PubMed ID: 38645153
[TBL] [Abstract][Full Text] [Related]
18. Translocation Renal Cell Carcinoma: An Update on Clinicopathological and Molecular Features.
Inamura K
Cancers (Basel); 2017 Aug; 9(9):. PubMed ID: 28850056
[TBL] [Abstract][Full Text] [Related]
19. Superficial ALK-rearranged myxoid spindle cell neoplasm: a cutaneous soft tissue tumor with distinctive morphology and immunophenotypic profile.
Dermawan JK; Azzato EM; Goldblum JR; Rubin BP; Billings SD; Ko JS
Mod Pathol; 2021 Sep; 34(9):1710-1718. PubMed ID: 34088997
[TBL] [Abstract][Full Text] [Related]
20. A review of ALK-rearranged renal cell carcinomas with a focus on clinical and pathobiological aspects.
Kuroda N; Sugawara E; Kusano H; Yuba Y; Yorita K; Takeuchi K
Pol J Pathol; 2018; 69(2):109-113. PubMed ID: 30351856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]